Please login to the form below

Not currently logged in
Email:
Password:

Remdesivir

This page shows the latest Remdesivir news and features for those working in and with pharma, biotech and healthcare.

US regulators set to approve oral antiviral against COVID-19

US regulators set to approve oral antiviral against COVID-19

Oral medications like molnupiravir and Paxlovid are significantly more convenient than the injectable COVID-19 treatments that are currently being used, including Gilead’s Veklury (remdesivir).

Latest news

More from news
Approximately 12 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    Trials) evaluating five-day and ten-day dosing durations of remdesivir in patients with severe disease. ... remdesivir”. Can you offer more details about the studies published in the aforementioned peer-reviewed journals?

  • Working together against COVID-19 Working together against COVID-19

    Gilead shared some positive updates on social media about remdesivir but did not address all HCP concerns. ... Subsequently, Gilead dropped remdesivir’s orphan drug designation based on its potential as a coronavirus treatment.

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    A subsequent leak about the apparent failure of remdesivir in a Chinese trial then dampened expectations again. ... Yet, it is unlikely that any of the drugs will be a panacea, with Jefferies analysts saying remdesivir “might be modestly helpful”.

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    An experimental antiviral: Gilead’s remdesivir. Gilead’s remdesivir, an experimental antiviral drug, is arguably the most-talked about potential treatment for COVID-19. ... Lane is currently overseeing ongoing studies at the US National Institutes of

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...